Helping older adults with acute myeloid leukemia and their caregivers make treatment decisions
A decisional intervention for older adults with acute myeloid leukemia and their caregivers
This study is all about helping older adults with acute myeloid leukemia and their caregivers make better decisions about treatment by providing support and information that reflects their values, so they can feel less stressed and improve their quality of life.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11045943 on NIH RePORTER |
What this research studies
This research focuses on improving the decision-making process for older adults diagnosed with acute myeloid leukemia (AML) and their caregivers. It aims to reduce psychological distress and enhance the quality of life by implementing a shared decision-making approach that incorporates patient values and treatment options. The study will involve a multilevel decisional intervention called UR-GOAL, which has been developed with input from patients and caregivers to ensure it meets their needs. Participants will receive support to understand their disease and treatment choices, helping them make informed decisions quickly.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 60 and above who have been diagnosed with acute myeloid leukemia and their caregivers.
Not a fit: Patients who are younger than 60 years old or do not have acute myeloid leukemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatment decisions and improved quality of life for older adults with AML and their caregivers.
How similar studies have performed: Previous research has shown that shared decision-making approaches can significantly reduce distress and improve outcomes for patients with serious illnesses, indicating a promising avenue for this intervention.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Loh, Kah Poh — University of Rochester
- Study coordinator: Loh, Kah Poh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.